Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model.

Autor: To B; Department of Physiology, Michigan State University, East Lansing, MI, USA., Broeker C; Department of Physiology, Michigan State University, East Lansing, MI, USA., Jhan JR; Department of Physiology, Michigan State University, East Lansing, MI, USA., Garcia-Lerena J; Department of Physiology, Michigan State University, East Lansing, MI, USA., Vusich J; Department of Physiology, Michigan State University, East Lansing, MI, USA., Rempel R; Duke University, Durham, USA., Rennhack JP; Department of Physiology, Michigan State University, East Lansing, MI, USA., Hollern D; The Salk Institute, San Diego, CA, USA., Jackson L; Department of Physiology, Michigan State University, East Lansing, MI, USA., Judah D; Department of Physiology, Michigan State University, East Lansing, MI, USA., Swiatnicki M; Department of Physiology, Michigan State University, East Lansing, MI, USA., Bylett E; Department of Physiology, Michigan State University, East Lansing, MI, USA., Kubiak R; Department of Physiology, Michigan State University, East Lansing, MI, USA., Honeysett J; Department of Physiology, Michigan State University, East Lansing, MI, USA., Nevins J; Duke University, Durham, USA., Andrechek E; Department of Physiology, Michigan State University, East Lansing, MI, USA. Andrech1@msu.edu.

Publikováno v: Oncogene [Oncogene] 2024 Nov; Vol. 43 (46), pp. 3402-3415. Date of Electronic Publication: 2024 Sep 28.

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence.

Autor: Leung, J Y¹, Andrechek, E R², Cardiff, R D³, Nevins, J R⁴

Publikováno v: Oncogene. 5/17/2012, Vol. 31 Issue 20, p2545-2554. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity.

Autor: Maccallini, Cristina¹ (AUTHOR) cristina.maccallini@unich.it, Budriesi, Roberta² (AUTHOR) roberta.budriesi@unibo.it, De Filippis, Barbara¹ (AUTHOR) rosa.amoroso@unich.it, Amoroso, Rosa¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8486. 16p.

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

Autor: Xiao T; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Li W; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115.; Center for Genetic Medicine Research, Children's National Health System, Washington, DC 20010.; Department of Genomics and Precision Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC 20010., Wang X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Xu H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Yang J; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; Department of Vascular and Endocrine Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China., Wu Q; School of Life Science and Technology, Tongji University, Shanghai 200092, China., Huang Y; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Geradts J; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Jiang P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Fei T; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; College of Life and Health Sciences, Northeastern University, Shenyang 110819, China., Chi D; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Zang C; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Liao Q; Department of Prevention Medicine, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China., Rennhack J; Department of Physiology, Michigan State University, East Lansing, MI 48864., Andrechek E; Department of Physiology, Michigan State University, East Lansing, MI 48864., Li N; Department of Vascular and Endocrine Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China., Detre S; Breast Cancer Now Research Centre, The Institute of Cancer Research, London SW7 3RP, United Kingdom., Dowsett M; Breast Cancer Now Research Centre, The Institute of Cancer Research, London SW7 3RP, United Kingdom., Jeselsohn RM; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Liu XS; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; xsliu@jimmy.harvard.edu myles_brown@dfci.harvard.edu.; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115.; School of Life Science and Technology, Tongji University, Shanghai 200092, China., Brown M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; xsliu@jimmy.harvard.edu myles_brown@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Jul 31; Vol. 115 (31), pp. 7869-7878. Date of Electronic Publication: 2018 Jul 09.